# Major Recall Alert: Natrilix SR (Indapamide 1.5mg) Recalled Due to Quality, Safety, and Efficacy Concerns
The National Agency for Food and Drug Administration and Control (NAFDAC) has raised a critical public alert regarding the circulation of revalidated and unregistered Natrilix SR (Indapamide 1.5mg), manufactured by SERVIER Egypt Industries Limited. The unregistered status and questions surrounding the drug’s quality, safety, and efficacy have necessitated an immediate recall effort. This development calls for heightened vigilance among distributors, retailers, and consumers in Nigeria’s pharmaceutical supply chain.
---
## Why This Recall is Important
Natrilix SR (Indapamide 1.5mg) is widely used to treat hypertension and associated complications. Medications like this play a crucial role in maintaining patients’ health, but circulating falsified or unregistered products poses significant risks to public health.
NAFDAC has flagged the product due to the following concerns:
- **Quality Issues**: The efficacy of the revalidated and unregistered batches is unverified. Patients who rely on this medication may face treatment failure or adverse reactions.
- **Safety Concerns**: The revalidated Natrilix SR bypassed the necessary quality standards. Consuming such products can lead to unpredictable side effects and compromise patient safety.
- **Efficacy Problems**: The unregistered nature of the product raises red flags about its ability to provide the intended health benefits. Using an ineffective or substandard drug could exacerbate health conditions.
By bringing attention to this recall, NAFDAC aims to protect consumers from potential harm and ensure that public health standards remain uncompromised.
---
## Details of the Recall
Here are the key details about this important recall:
- **Product Name**: Natrilix SR (Indapamide 1.5mg)
- **Manufacturer**: SERVIER Egypt Industries Limited
- **Reason for Recall**: Circulation of revalidated and unregistered products with concerns about quality, safety, and efficacy.
- **Safety Advisory**: All distributors, retailers, healthcare professionals, and caregivers are instructed to avoid selling, purchasing, or administering the affected drug.
- **Incident Date**: The issue was officially announced on **31148** (exact date pending clarification).
- **Images of the Affected Product**:
[](https://nafdac.gov.ng/wp-content/uploads/2026/01/image-1.png)
[](https://nafdac.gov.ng/wp-content/uploads/2026/01/image2.png)
NAFDAC is actively monitoring the recall process to ensure the unregistered batches of Natrilix SR are removed from circulation expeditiously.
---
## What You Should Do
If you are a distributor, retailer, healthcare professional, or consumer who deals with Natrilix SR, it is crucial to follow these steps to prevent the use of the unsafe product:
- **Check your supply**: Inspect all Natrilix SR (Indapamide 1.5mg) products in your possession to ensure they are registered and meet quality standards.
- **Avoid use or sale**: Do not sell, prescribe, or consume the flagged product under any circumstances.
- **Report immediately**: Notify NAFDAC promptly if you spot any suspected falsified or compromised drugs. Reports can be filed with your nearest NAFDAC office or through designated communication channels.
- **Spread awareness**: Educate your networks about this recall to prevent further distribution or harm.
For additional details about the recall, visit the official NAFDAC page here: [NAFDAC Public Alert No. 02/2026](https://nafdac.gov.ng/public-alert-no-02-2026-alert-on-revalidated-and-unregistered-natrilix-sr-found-on-sale/).
---
## Stay Safe – Get Instant Recall Alerts
Protecting yourself and your loved ones from unsafe products is easier than ever. Stay informed about the latest recalls and public safety updates by downloading the NAFDAC Consumer Protection App today. Through this app, you can:
- Receive instant notifications about recalls and safety alerts.
- Report falsified or compromised products quickly.
- Access a verified database of registered pharmaceutical products.
Don’t compromise on your health—**[Download the NAFDAC App Now](https://nafdac.gov.ng)** and stay one step ahead in safeguarding your medications and healthcare solutions.
---
This recall emphasizes the need for stringent monitoring and proactive action to eliminate falsified pharmaceuticals from the market. Adhering to NAFDAC's safety guidelines is imperative to safeguard public health and maintain confidence in Nigeria’s medicine supply chain. Stay vigilant, and always prioritize registered, high-quality products for your safety.